Literature DB >> 19468804

Postoperative suppression of inflammatory cytokines after distal gastrectomy in elderly patients.

Kyo Kishimoto1, Manabu Hiraguri, Naohiko Koide, Kazuhiro Hanazaki, Wataru Adachi.   

Abstract

PURPOSE: Surgical procedures are being performed on elderly people with increasing frequency, but accordingly, postoperative complications and mortality rates are higher than for younger patients. We conducted this study to establish if cytokine responses after distal gastrectomy in elderly patients differ from those in younger patients.
METHODS: Twenty-one patients undergoing distal gastrectomy were divided into two groups based on age: the elderly group consisted of 10 patients aged >/=75 years, and the younger group consisted of 11 patients aged <65 years. Blood samples were collected from the patients preoperatively, and then on postoperative days (PODs) 1, 3, and 7, for analysis of interleukin (IL)-6, IL-8, IL-10, soluble tumor necrosis factor receptors (sTNF-R), and IL-1 receptor antagonist (IL-1ra); and also to measure TNF-alpha and IL-1beta after incubation with Escherichia coli lipopolysaccharide.
RESULTS: The IL-6 concentration and TNF-alpha on POD 1 were both significantly lower in the elderly group than in the younger group (P = 0.0058 and P = 0.022, respectively).
CONCLUSION: Cytokine profiles after distal gastrectomy in elderly patients differ from those in younger patients, with lower pro-inflammatory and inflammatory cytokine responses evident in the elderly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468804     DOI: 10.1007/s00595-008-3907-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  35 in total

1.  Regulation of human IL-18 mRNA expression.

Authors:  J D Marshall; M Aste-Amézaga; S S Chehimi; M Murphy; H Olsen; G Trinchieri
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

2.  The outcome of surgical treatment for gastric carcinoma in the elderly.

Authors:  H Katai; M Sasako; T Sano; K Maruyama
Journal:  Jpn J Clin Oncol       Date:  1998-02       Impact factor: 3.019

3.  Plasma proinflammatory cytokine response to surgical stress in elderly patients.

Authors:  A Kudoh; H Katagai; T Takazawa; A Matsuki
Journal:  Cytokine       Date:  2001-09-07       Impact factor: 3.861

4.  Interleukin-6 production does not increase with age.

Authors:  A A Beharka; M Meydani; D Wu; L S Leka; A Meydani; S N Meydani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-02       Impact factor: 6.053

5.  Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure.

Authors:  D A Partrick; F A Moore; E E Moore; W L Biffl; A Sauaia; C C Barnett
Journal:  Am J Surg       Date:  1996-11       Impact factor: 2.565

6.  Endogenous IL-10 protects mice from death during septic peritonitis.

Authors:  T van der Poll; A Marchant; W A Buurman; L Berman; C V Keogh; D D Lazarus; L Nguyen; M Goldman; L L Moldawer; S F Lowry
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

7.  Interleukin-6 delays neutrophil apoptosis.

Authors:  W L Biffl; E E Moore; F A Moore; C C Barnett; V S Carl; V N Peterson
Journal:  Arch Surg       Date:  1996-01

8.  Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.

Authors:  Shintaro Akamoto; Keiichi Okano; Takanori Sano; Shinichi Yachida; Kunihiko Izuishi; Hisashi Usuki; Hisao Wakabayashi; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

9.  Production of interleukin-6 at operative wound sites in surgical patients.

Authors:  H Ueo; H Inoue; M Honda; I Uchida; M Nishimura; S Arinaga; H Nakashima; T Akiyoshi
Journal:  J Am Coll Surg       Date:  1994-09       Impact factor: 6.113

10.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  5 in total

1.  Measurement of tumour necrosis factor receptors for immune response in colon cancer patients.

Authors:  K Venetsanou; V Kaldis; N Kouzanidis; Ch Papazacharias; J Paraskevopoulos; G Baltopoulos
Journal:  Clin Exp Med       Date:  2011-11-01       Impact factor: 3.984

2.  Butyrate protects rats from hepatic ischemia/reperfusion injury.

Authors:  Bin Liu; Zhen-Yu Ma; Gang Wu; Jian-Min Qian
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia/reperfusion in rats.

Authors:  Feng Zhang; Xun Wang; Liquan Tong; Haiquan Qiao; Xinlei Li; Liguang You; Hongchi Jiang; Xueying Sun
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

4.  IL-6 serum levels predict postoperative morbidity in gastric cancer patients.

Authors:  Antoni M Szczepanik; Lucyna Scislo; Thecla Scully; Elzbieta Walewska; Maciej Siedlar; Piotr Kolodziejczyk; Marzena Lenart; Magdalena Rutkowska; Aleksander Galas; Antoni Czupryna; Jan Kulig
Journal:  Gastric Cancer       Date:  2011-04-20       Impact factor: 7.370

5.  The circRNA_102911/miR-129-5p/SOX6 axis is involved with T lymphocyte immune function in elderly patients with laparoscopic left hepatectomy for hepatolithiasis.

Authors:  Hongqiang Zhao; Xiaoyu Shao; Haorun Liu; Qi Liu; Jiangyang Lu; Weimin Li
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.